nodes	percent_of_prediction	percent_of_DWPC	metapath
Flumazenil—Tetany—Cisplatin—bone cancer	0.0473	0.0473	CcSEcCtD
Flumazenil—Hearing impaired—Cisplatin—bone cancer	0.0162	0.0162	CcSEcCtD
Flumazenil—Pain—Carboplatin—bone cancer	0.016	0.016	CcSEcCtD
Flumazenil—Hiccups—Cisplatin—bone cancer	0.0154	0.0154	CcSEcCtD
Flumazenil—Deafness—Cisplatin—bone cancer	0.0125	0.0125	CcSEcCtD
Flumazenil—Nasal congestion—Cisplatin—bone cancer	0.0123	0.0123	CcSEcCtD
Flumazenil—Redness—Epirubicin—bone cancer	0.0117	0.0117	CcSEcCtD
Flumazenil—Hyperventilation—Epirubicin—bone cancer	0.0115	0.0115	CcSEcCtD
Flumazenil—Stupor—Methotrexate—bone cancer	0.0113	0.0113	CcSEcCtD
Flumazenil—Redness—Doxorubicin—bone cancer	0.0108	0.0108	CcSEcCtD
Flumazenil—Hyperventilation—Doxorubicin—bone cancer	0.0106	0.0106	CcSEcCtD
Flumazenil—Scotoma—Epirubicin—bone cancer	0.0104	0.0104	CcSEcCtD
Flumazenil—Speech disorder—Methotrexate—bone cancer	0.00983	0.00983	CcSEcCtD
Flumazenil—Injection site pain—Epirubicin—bone cancer	0.00969	0.00969	CcSEcCtD
Flumazenil—Rigors—Epirubicin—bone cancer	0.00969	0.00969	CcSEcCtD
Flumazenil—Scotoma—Doxorubicin—bone cancer	0.00964	0.00964	CcSEcCtD
Flumazenil—Dysphonia—Epirubicin—bone cancer	0.00962	0.00962	CcSEcCtD
Flumazenil—Sweating increased—Cisplatin—bone cancer	0.00942	0.00942	CcSEcCtD
Flumazenil—Delirium—Epirubicin—bone cancer	0.0092	0.0092	CcSEcCtD
Flumazenil—Vasodilation procedure—Epirubicin—bone cancer	0.009	0.009	CcSEcCtD
Flumazenil—Vasodilation—Epirubicin—bone cancer	0.009	0.009	CcSEcCtD
Flumazenil—Injection site pain—Doxorubicin—bone cancer	0.00897	0.00897	CcSEcCtD
Flumazenil—Rigors—Doxorubicin—bone cancer	0.00897	0.00897	CcSEcCtD
Flumazenil—Dysphonia—Doxorubicin—bone cancer	0.0089	0.0089	CcSEcCtD
Flumazenil—Ventricular extrasystoles—Epirubicin—bone cancer	0.00876	0.00876	CcSEcCtD
Flumazenil—Delirium—Doxorubicin—bone cancer	0.00851	0.00851	CcSEcCtD
Flumazenil—Vasodilation procedure—Doxorubicin—bone cancer	0.00833	0.00833	CcSEcCtD
Flumazenil—Vasodilation—Doxorubicin—bone cancer	0.00833	0.00833	CcSEcCtD
Flumazenil—Depressed level of consciousness—Methotrexate—bone cancer	0.00816	0.00816	CcSEcCtD
Flumazenil—Ventricular extrasystoles—Doxorubicin—bone cancer	0.00811	0.00811	CcSEcCtD
Flumazenil—Ventricular tachycardia—Epirubicin—bone cancer	0.00791	0.00791	CcSEcCtD
Flumazenil—Hiccups—Epirubicin—bone cancer	0.00791	0.00791	CcSEcCtD
Flumazenil—Bradycardia—Cisplatin—bone cancer	0.00788	0.00788	CcSEcCtD
Flumazenil—Injection site reaction—Epirubicin—bone cancer	0.00787	0.00787	CcSEcCtD
Flumazenil—Salivary hypersecretion—Epirubicin—bone cancer	0.00768	0.00768	CcSEcCtD
Flumazenil—Visual impairment—Cisplatin—bone cancer	0.00746	0.00746	CcSEcCtD
Flumazenil—Hiccups—Doxorubicin—bone cancer	0.00732	0.00732	CcSEcCtD
Flumazenil—Ventricular tachycardia—Doxorubicin—bone cancer	0.00732	0.00732	CcSEcCtD
Flumazenil—Injection site reaction—Doxorubicin—bone cancer	0.00728	0.00728	CcSEcCtD
Flumazenil—Tinnitus—Cisplatin—bone cancer	0.00721	0.00721	CcSEcCtD
Flumazenil—Flushing—Cisplatin—bone cancer	0.00718	0.00718	CcSEcCtD
Flumazenil—Salivary hypersecretion—Doxorubicin—bone cancer	0.00711	0.00711	CcSEcCtD
Flumazenil—Thrombophlebitis—Methotrexate—bone cancer	0.00709	0.00709	CcSEcCtD
Flumazenil—Arrhythmia—Cisplatin—bone cancer	0.00691	0.00691	CcSEcCtD
Flumazenil—Abnormal vision—Epirubicin—bone cancer	0.0069	0.0069	CcSEcCtD
Flumazenil—Erythema—Cisplatin—bone cancer	0.00674	0.00674	CcSEcCtD
Flumazenil—Thrombophlebitis—Epirubicin—bone cancer	0.00663	0.00663	CcSEcCtD
Flumazenil—Abnormal vision—Doxorubicin—bone cancer	0.00638	0.00638	CcSEcCtD
Flumazenil—Vision blurred—Cisplatin—bone cancer	0.00635	0.00635	CcSEcCtD
Flumazenil—Tremor—Cisplatin—bone cancer	0.00631	0.00631	CcSEcCtD
Flumazenil—Ill-defined disorder—Cisplatin—bone cancer	0.00625	0.00625	CcSEcCtD
Flumazenil—Hot flush—Epirubicin—bone cancer	0.00614	0.00614	CcSEcCtD
Flumazenil—Thrombophlebitis—Doxorubicin—bone cancer	0.00614	0.00614	CcSEcCtD
Flumazenil—Menopausal symptoms—Epirubicin—bone cancer	0.00609	0.00609	CcSEcCtD
Flumazenil—Malaise—Cisplatin—bone cancer	0.00607	0.00607	CcSEcCtD
Flumazenil—Mood swings—Methotrexate—bone cancer	0.00581	0.00581	CcSEcCtD
Flumazenil—Ataxia—Methotrexate—bone cancer	0.00577	0.00577	CcSEcCtD
Flumazenil—Diplopia—Epirubicin—bone cancer	0.00574	0.00574	CcSEcCtD
Flumazenil—Anxiety—Cisplatin—bone cancer	0.00571	0.00571	CcSEcCtD
Flumazenil—Hot flush—Doxorubicin—bone cancer	0.00568	0.00568	CcSEcCtD
Flumazenil—Discomfort—Cisplatin—bone cancer	0.00567	0.00567	CcSEcCtD
Flumazenil—Affect lability—Epirubicin—bone cancer	0.00565	0.00565	CcSEcCtD
Flumazenil—Menopausal symptoms—Doxorubicin—bone cancer	0.00563	0.00563	CcSEcCtD
Flumazenil—Mood swings—Epirubicin—bone cancer	0.00544	0.00544	CcSEcCtD
Flumazenil—Ataxia—Epirubicin—bone cancer	0.0054	0.0054	CcSEcCtD
Flumazenil—Tachycardia—Cisplatin—bone cancer	0.00536	0.00536	CcSEcCtD
Flumazenil—Diplopia—Doxorubicin—bone cancer	0.00531	0.00531	CcSEcCtD
Flumazenil—Hyperhidrosis—Cisplatin—bone cancer	0.00531	0.00531	CcSEcCtD
Flumazenil—Affect lability—Doxorubicin—bone cancer	0.00523	0.00523	CcSEcCtD
Flumazenil—Hypotension—Cisplatin—bone cancer	0.00514	0.00514	CcSEcCtD
Flumazenil—Mood swings—Doxorubicin—bone cancer	0.00503	0.00503	CcSEcCtD
Flumazenil—Ataxia—Doxorubicin—bone cancer	0.005	0.005	CcSEcCtD
Flumazenil—Paraesthesia—Cisplatin—bone cancer	0.00494	0.00494	CcSEcCtD
Flumazenil—Dyspnoea—Cisplatin—bone cancer	0.0049	0.0049	CcSEcCtD
Flumazenil—Drowsiness—Methotrexate—bone cancer	0.00473	0.00473	CcSEcCtD
Flumazenil—Pain—Cisplatin—bone cancer	0.0047	0.0047	CcSEcCtD
Flumazenil—Sweating—Methotrexate—bone cancer	0.00453	0.00453	CcSEcCtD
Flumazenil—Feeling abnormal—Cisplatin—bone cancer	0.00453	0.00453	CcSEcCtD
Flumazenil—Drowsiness—Epirubicin—bone cancer	0.00443	0.00443	CcSEcCtD
Flumazenil—Sweating—Epirubicin—bone cancer	0.00424	0.00424	CcSEcCtD
Flumazenil—Drowsiness—Doxorubicin—bone cancer	0.0041	0.0041	CcSEcCtD
Flumazenil—Visual impairment—Methotrexate—bone cancer	0.00409	0.00409	CcSEcCtD
Flumazenil—Hypersensitivity—Cisplatin—bone cancer	0.00405	0.00405	CcSEcCtD
Flumazenil—Bradycardia—Epirubicin—bone cancer	0.00404	0.00404	CcSEcCtD
Flumazenil—Tinnitus—Methotrexate—bone cancer	0.00396	0.00396	CcSEcCtD
Flumazenil—Hypoaesthesia—Epirubicin—bone cancer	0.00395	0.00395	CcSEcCtD
Flumazenil—Asthenia—Cisplatin—bone cancer	0.00394	0.00394	CcSEcCtD
Flumazenil—Sweating—Doxorubicin—bone cancer	0.00393	0.00393	CcSEcCtD
Flumazenil—Visual impairment—Epirubicin—bone cancer	0.00383	0.00383	CcSEcCtD
Flumazenil—Chills—Methotrexate—bone cancer	0.00381	0.00381	CcSEcCtD
Flumazenil—Bradycardia—Doxorubicin—bone cancer	0.00374	0.00374	CcSEcCtD
Flumazenil—Tinnitus—Epirubicin—bone cancer	0.0037	0.0037	CcSEcCtD
Flumazenil—Erythema—Methotrexate—bone cancer	0.0037	0.0037	CcSEcCtD
Flumazenil—Flushing—Epirubicin—bone cancer	0.00369	0.00369	CcSEcCtD
Flumazenil—Hypoaesthesia—Doxorubicin—bone cancer	0.00366	0.00366	CcSEcCtD
Flumazenil—Chills—Epirubicin—bone cancer	0.00357	0.00357	CcSEcCtD
Flumazenil—Arrhythmia—Epirubicin—bone cancer	0.00355	0.00355	CcSEcCtD
Flumazenil—Visual impairment—Doxorubicin—bone cancer	0.00354	0.00354	CcSEcCtD
Flumazenil—Vomiting—Cisplatin—bone cancer	0.0035	0.0035	CcSEcCtD
Flumazenil—Vision blurred—Methotrexate—bone cancer	0.00348	0.00348	CcSEcCtD
Flumazenil—Rash—Cisplatin—bone cancer	0.00347	0.00347	CcSEcCtD
Flumazenil—Dermatitis—Cisplatin—bone cancer	0.00346	0.00346	CcSEcCtD
Flumazenil—Erythema—Epirubicin—bone cancer	0.00346	0.00346	CcSEcCtD
Flumazenil—Ill-defined disorder—Methotrexate—bone cancer	0.00343	0.00343	CcSEcCtD
Flumazenil—Tinnitus—Doxorubicin—bone cancer	0.00343	0.00343	CcSEcCtD
Flumazenil—Flushing—Doxorubicin—bone cancer	0.00341	0.00341	CcSEcCtD
Flumazenil—Tension—Epirubicin—bone cancer	0.00339	0.00339	CcSEcCtD
Flumazenil—Nervousness—Epirubicin—bone cancer	0.00336	0.00336	CcSEcCtD
Flumazenil—Malaise—Methotrexate—bone cancer	0.00333	0.00333	CcSEcCtD
Flumazenil—Vertigo—Methotrexate—bone cancer	0.00332	0.00332	CcSEcCtD
Flumazenil—Chills—Doxorubicin—bone cancer	0.0033	0.0033	CcSEcCtD
Flumazenil—Arrhythmia—Doxorubicin—bone cancer	0.00328	0.00328	CcSEcCtD
Flumazenil—Nausea—Cisplatin—bone cancer	0.00327	0.00327	CcSEcCtD
Flumazenil—Vision blurred—Epirubicin—bone cancer	0.00326	0.00326	CcSEcCtD
Flumazenil—Cough—Methotrexate—bone cancer	0.00323	0.00323	CcSEcCtD
Flumazenil—Ill-defined disorder—Epirubicin—bone cancer	0.00321	0.00321	CcSEcCtD
Flumazenil—Erythema—Doxorubicin—bone cancer	0.0032	0.0032	CcSEcCtD
Flumazenil—Agitation—Epirubicin—bone cancer	0.00318	0.00318	CcSEcCtD
Flumazenil—Chest pain—Methotrexate—bone cancer	0.00315	0.00315	CcSEcCtD
Flumazenil—Tension—Doxorubicin—bone cancer	0.00314	0.00314	CcSEcCtD
Flumazenil—Malaise—Epirubicin—bone cancer	0.00312	0.00312	CcSEcCtD
Flumazenil—Discomfort—Methotrexate—bone cancer	0.00311	0.00311	CcSEcCtD
Flumazenil—Nervousness—Doxorubicin—bone cancer	0.00311	0.00311	CcSEcCtD
Flumazenil—Vertigo—Epirubicin—bone cancer	0.00311	0.00311	CcSEcCtD
Flumazenil—Palpitations—Epirubicin—bone cancer	0.00306	0.00306	CcSEcCtD
Flumazenil—Confusional state—Methotrexate—bone cancer	0.00304	0.00304	CcSEcCtD
Flumazenil—Cough—Epirubicin—bone cancer	0.00302	0.00302	CcSEcCtD
Flumazenil—Vision blurred—Doxorubicin—bone cancer	0.00302	0.00302	CcSEcCtD
Flumazenil—Hypertension—Epirubicin—bone cancer	0.00299	0.00299	CcSEcCtD
Flumazenil—Ill-defined disorder—Doxorubicin—bone cancer	0.00297	0.00297	CcSEcCtD
Flumazenil—Chest pain—Epirubicin—bone cancer	0.00294	0.00294	CcSEcCtD
Flumazenil—Agitation—Doxorubicin—bone cancer	0.00294	0.00294	CcSEcCtD
Flumazenil—Anxiety—Epirubicin—bone cancer	0.00293	0.00293	CcSEcCtD
Flumazenil—Hyperhidrosis—Methotrexate—bone cancer	0.00292	0.00292	CcSEcCtD
Flumazenil—Discomfort—Epirubicin—bone cancer	0.00291	0.00291	CcSEcCtD
Flumazenil—Malaise—Doxorubicin—bone cancer	0.00289	0.00289	CcSEcCtD
Flumazenil—Dry mouth—Epirubicin—bone cancer	0.00288	0.00288	CcSEcCtD
Flumazenil—Vertigo—Doxorubicin—bone cancer	0.00288	0.00288	CcSEcCtD
Flumazenil—Confusional state—Epirubicin—bone cancer	0.00285	0.00285	CcSEcCtD
Flumazenil—Palpitations—Doxorubicin—bone cancer	0.00283	0.00283	CcSEcCtD
Flumazenil—Hypotension—Methotrexate—bone cancer	0.00282	0.00282	CcSEcCtD
Flumazenil—Cough—Doxorubicin—bone cancer	0.00279	0.00279	CcSEcCtD
Flumazenil—Hypertension—Doxorubicin—bone cancer	0.00276	0.00276	CcSEcCtD
Flumazenil—Tachycardia—Epirubicin—bone cancer	0.00276	0.00276	CcSEcCtD
Flumazenil—Hyperhidrosis—Epirubicin—bone cancer	0.00273	0.00273	CcSEcCtD
Flumazenil—Insomnia—Methotrexate—bone cancer	0.00273	0.00273	CcSEcCtD
Flumazenil—Chest pain—Doxorubicin—bone cancer	0.00272	0.00272	CcSEcCtD
Flumazenil—Anxiety—Doxorubicin—bone cancer	0.00272	0.00272	CcSEcCtD
Flumazenil—Paraesthesia—Methotrexate—bone cancer	0.00271	0.00271	CcSEcCtD
Flumazenil—Discomfort—Doxorubicin—bone cancer	0.00269	0.00269	CcSEcCtD
Flumazenil—Dyspnoea—Methotrexate—bone cancer	0.00269	0.00269	CcSEcCtD
Flumazenil—Somnolence—Methotrexate—bone cancer	0.00268	0.00268	CcSEcCtD
Flumazenil—Dry mouth—Doxorubicin—bone cancer	0.00266	0.00266	CcSEcCtD
Flumazenil—Hypotension—Epirubicin—bone cancer	0.00264	0.00264	CcSEcCtD
Flumazenil—Confusional state—Doxorubicin—bone cancer	0.00263	0.00263	CcSEcCtD
Flumazenil—Fatigue—Methotrexate—bone cancer	0.0026	0.0026	CcSEcCtD
Flumazenil—Pain—Methotrexate—bone cancer	0.00258	0.00258	CcSEcCtD
Flumazenil—Insomnia—Epirubicin—bone cancer	0.00255	0.00255	CcSEcCtD
Flumazenil—Tachycardia—Doxorubicin—bone cancer	0.00255	0.00255	CcSEcCtD
Flumazenil—Paraesthesia—Epirubicin—bone cancer	0.00253	0.00253	CcSEcCtD
Flumazenil—Hyperhidrosis—Doxorubicin—bone cancer	0.00253	0.00253	CcSEcCtD
Flumazenil—Dyspnoea—Epirubicin—bone cancer	0.00252	0.00252	CcSEcCtD
Flumazenil—Somnolence—Epirubicin—bone cancer	0.00251	0.00251	CcSEcCtD
Flumazenil—Feeling abnormal—Methotrexate—bone cancer	0.00249	0.00249	CcSEcCtD
Flumazenil—Hypotension—Doxorubicin—bone cancer	0.00244	0.00244	CcSEcCtD
Flumazenil—Fatigue—Epirubicin—bone cancer	0.00243	0.00243	CcSEcCtD
Flumazenil—Pain—Epirubicin—bone cancer	0.00241	0.00241	CcSEcCtD
Flumazenil—Urticaria—Methotrexate—bone cancer	0.0024	0.0024	CcSEcCtD
Flumazenil—Insomnia—Doxorubicin—bone cancer	0.00236	0.00236	CcSEcCtD
Flumazenil—Paraesthesia—Doxorubicin—bone cancer	0.00235	0.00235	CcSEcCtD
Flumazenil—Dyspnoea—Doxorubicin—bone cancer	0.00233	0.00233	CcSEcCtD
Flumazenil—Feeling abnormal—Epirubicin—bone cancer	0.00233	0.00233	CcSEcCtD
Flumazenil—Somnolence—Doxorubicin—bone cancer	0.00232	0.00232	CcSEcCtD
Flumazenil—Fatigue—Doxorubicin—bone cancer	0.00225	0.00225	CcSEcCtD
Flumazenil—Urticaria—Epirubicin—bone cancer	0.00224	0.00224	CcSEcCtD
Flumazenil—Pain—Doxorubicin—bone cancer	0.00223	0.00223	CcSEcCtD
Flumazenil—Hypersensitivity—Methotrexate—bone cancer	0.00222	0.00222	CcSEcCtD
Flumazenil—Asthenia—Methotrexate—bone cancer	0.00216	0.00216	CcSEcCtD
Flumazenil—Feeling abnormal—Doxorubicin—bone cancer	0.00215	0.00215	CcSEcCtD
Flumazenil—Pruritus—Methotrexate—bone cancer	0.00213	0.00213	CcSEcCtD
Flumazenil—Hypersensitivity—Epirubicin—bone cancer	0.00208	0.00208	CcSEcCtD
Flumazenil—Urticaria—Doxorubicin—bone cancer	0.00207	0.00207	CcSEcCtD
Flumazenil—Asthenia—Epirubicin—bone cancer	0.00203	0.00203	CcSEcCtD
Flumazenil—Pruritus—Epirubicin—bone cancer	0.002	0.002	CcSEcCtD
Flumazenil—Dizziness—Methotrexate—bone cancer	0.00199	0.00199	CcSEcCtD
Flumazenil—Hypersensitivity—Doxorubicin—bone cancer	0.00192	0.00192	CcSEcCtD
Flumazenil—Vomiting—Methotrexate—bone cancer	0.00192	0.00192	CcSEcCtD
Flumazenil—Rash—Methotrexate—bone cancer	0.0019	0.0019	CcSEcCtD
Flumazenil—Dermatitis—Methotrexate—bone cancer	0.0019	0.0019	CcSEcCtD
Flumazenil—Headache—Methotrexate—bone cancer	0.00189	0.00189	CcSEcCtD
Flumazenil—Asthenia—Doxorubicin—bone cancer	0.00187	0.00187	CcSEcCtD
Flumazenil—Dizziness—Epirubicin—bone cancer	0.00187	0.00187	CcSEcCtD
Flumazenil—Pruritus—Doxorubicin—bone cancer	0.00185	0.00185	CcSEcCtD
Flumazenil—Vomiting—Epirubicin—bone cancer	0.00179	0.00179	CcSEcCtD
Flumazenil—Nausea—Methotrexate—bone cancer	0.00179	0.00179	CcSEcCtD
Flumazenil—Rash—Epirubicin—bone cancer	0.00178	0.00178	CcSEcCtD
Flumazenil—Dermatitis—Epirubicin—bone cancer	0.00178	0.00178	CcSEcCtD
Flumazenil—Headache—Epirubicin—bone cancer	0.00177	0.00177	CcSEcCtD
Flumazenil—Dizziness—Doxorubicin—bone cancer	0.00173	0.00173	CcSEcCtD
Flumazenil—Nausea—Epirubicin—bone cancer	0.00168	0.00168	CcSEcCtD
Flumazenil—Vomiting—Doxorubicin—bone cancer	0.00166	0.00166	CcSEcCtD
Flumazenil—Rash—Doxorubicin—bone cancer	0.00165	0.00165	CcSEcCtD
Flumazenil—Dermatitis—Doxorubicin—bone cancer	0.00165	0.00165	CcSEcCtD
Flumazenil—Headache—Doxorubicin—bone cancer	0.00164	0.00164	CcSEcCtD
Flumazenil—Nausea—Doxorubicin—bone cancer	0.00155	0.00155	CcSEcCtD
